Core Insights - Autonomix Medical, Inc. is focused on innovative technologies for diagnosing and treating diseases of the nervous system [3][4] - The company will present at the LSI USA '25 Emerging Medtech Summit on March 18, 2025 [1][2] - Autonomix's technology includes a catheter-based microchip sensing array with approximately 3,000 times greater sensitivity than current technologies [3] Company Overview - Autonomix Medical, Inc. specializes in medical devices aimed at revolutionizing the diagnosis and treatment of nervous system diseases [3] - The company's platform technology is designed for transvascular diagnosis and treatment of peripheral nervous system diseases [3][4] - Initial development focuses on pain treatment, particularly for pancreatic cancer, which currently lacks reliable solutions [4] Technology and Applications - The technology is investigational and not yet cleared for marketing in the United States [4] - The platform has potential applications across various medical fields, including cardiology, hypertension, and chronic pain management [4]
Autonomix Medical, Inc. (NASDAQ: AMIX) to Present at the LSI USA ’25 Emerging Medtech Summit